These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 8932980)
41. Antitumor activity of a piperidine phospholipid. Houlihan WJ; Lee ML; Munder PG; Handley DA; Nemecek GA; Jaeggi CS; Winslow CW Arzneimittelforschung; 1994 Dec; 44(12):1384-8. PubMed ID: 7848363 [TBL] [Abstract][Full Text] [Related]
42. The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions. Kulikov VI; Muzya GI Biochemistry (Mosc); 1998 Jan; 63(1):47-54. PubMed ID: 9526094 [TBL] [Abstract][Full Text] [Related]
43. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells. Dichmann S; Rheinen H; Panther E; Herouy Y; Czech W; Termeer C; Simon JC; Gebicke-Haerter PJ; Norgauer J J Cell Physiol; 2000 Dec; 185(3):394-400. PubMed ID: 11056009 [TBL] [Abstract][Full Text] [Related]
44. Cell kill and cytostasis by ET-18-OCH3 and heat. Fujiwara K; Modest EJ; Wallen CA Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017 [TBL] [Abstract][Full Text] [Related]
45. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells. Noseda A; Berens ME; White JG; Modest EJ Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458 [TBL] [Abstract][Full Text] [Related]
46. Role of platelet-activating factor in reproduction: sperm function. Roudebush WE Asian J Androl; 2001 Jun; 3(2):81-5. PubMed ID: 11404790 [TBL] [Abstract][Full Text] [Related]
47. Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor. Dupré DJ; Thompson C; Chen Z; Rollin S; Larrivée JF; Le Gouill C; Rola-Pleszczynski M; Stanková J Cell Signal; 2007 Oct; 19(10):2068-79. PubMed ID: 17609120 [TBL] [Abstract][Full Text] [Related]
48. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro. Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383 [TBL] [Abstract][Full Text] [Related]
49. Impact of alkylphospholipids on the gene expression profile of HaCaT cells. Semini G; Klein A; Danker K Pharmacogenet Genomics; 2011 Jul; 21(7):375-87. PubMed ID: 21681147 [TBL] [Abstract][Full Text] [Related]
50. [Synthesis of phosphono analogs of a phospholipid platelet activating factor]. Chuvilin AN; Trusov VG; Serebrennikova GA Bioorg Khim; 1992 Jun; 18(6):862-70. PubMed ID: 1418000 [TBL] [Abstract][Full Text] [Related]
51. Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat. Hofmann B; Meisgeier U; Kertscher P; Ostermann G Biomed Biochim Acta; 1988; 47(10-11):S161-4. PubMed ID: 3150268 [TBL] [Abstract][Full Text] [Related]
52. Glutamine synthetase activity and HSP70 levels in cultured rat astrocytes: effect of 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. Renis M; Cardile V; Russo A; Campisi A; Collovà F Brain Res; 1998 Feb; 783(1):143-50. PubMed ID: 9479063 [TBL] [Abstract][Full Text] [Related]
53. A flow cytometric assay reveals an enhancement of phagocytosis by platelet activating factor in murine peritoneal macrophages. Ichinose M; Hara N; Sawada M; Maeno T Cell Immunol; 1994 Jul; 156(2):508-18. PubMed ID: 8025959 [TBL] [Abstract][Full Text] [Related]
54. Agonist-induced down-regulation of platelet-activating factor receptor gene expression in U937 cells. Chau LY; Peck K; Yen HH; Wang JY Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):911-6. PubMed ID: 7519853 [TBL] [Abstract][Full Text] [Related]
55. Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells. Workman P; Donaldson J; Lohmeyer M Biochem Pharmacol; 1991 Jan; 41(2):319-22. PubMed ID: 1989642 [No Abstract] [Full Text] [Related]
56. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine. Zhou X; Lu X; Arthur G Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233 [TBL] [Abstract][Full Text] [Related]
57. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro. Storme GA; Berdel WE; van Blitterswijk WJ; Bruyneel EA; De Bruyne GK; Mareel MM Cancer Res; 1985 Jan; 45(1):351-7. PubMed ID: 4038380 [TBL] [Abstract][Full Text] [Related]
58. Tumor necrosis factor release by murine macrophages stimulated by the cytotoxic ether lipid 1-O-hexadecyl-2-O-methyl-SN-glycero-3-phosphorylcholine (ET-18-O-OCH3). Shames R; Ruis NM; Valone FH Int J Immunopharmacol; 1994 Apr; 16(4):335-43. PubMed ID: 8045673 [TBL] [Abstract][Full Text] [Related]
59. Human conjunctival epithelial cell responses to platelet-activating factor (PAF): signal transduction and release of proinflammatory cytokines. Sharif NA; Xu S; Hellberg PE; Pang IH; Gamache DA; Yanni JM Mol Vis; 2009 Jun; 15():1153-61. PubMed ID: 19513187 [TBL] [Abstract][Full Text] [Related]
60. Platelet-activating factor (PAF) enhances apoptosis induced by ultraviolet radiation in corneal epithelial cells through cytochrome c-caspase activation. Ma X; Bazan HE Curr Eye Res; 2001 Nov; 23(5):326-35. PubMed ID: 11910521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]